VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 66 filers reported holding VINCERX PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $143,000 | -67.1% | 108,459 | 0.0% | 0.01% | -42.9% |
| Q1 2022 | $434,000 | -60.6% | 108,459 | +0.3% | 0.01% | -65.0% |
| Q4 2021 | $1,102,000 | +14.0% | 108,159 | +80.8% | 0.04% | +37.9% |
| Q3 2021 | $967,000 | -65.2% | 59,809 | -72.1% | 0.03% | -66.7% |
| Q2 2021 | $2,780,000 | -3.7% | 214,033 | +43.2% | 0.09% | +6.1% |
| Q1 2021 | $2,886,000 | -4.2% | 149,516 | +3.8% | 0.08% | -24.8% |
| Q4 2020 | $3,011,000 | – | 144,015 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,618,199 | $31,231,000 | 10.26% |
| Affinity Asset Advisors, LLC | 543,010 | $10,480,000 | 3.56% |
| ACUTA CAPITAL PARTNERS, LLC | 394,000 | $7,604,000 | 2.74% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $9,650,000 | 2.72% |
| Logos Global Management LP | 480,000 | $9,264,000 | 0.90% |
| Sio Capital Management, LLC | 105,000 | $2,027,000 | 0.41% |
| SABBY MANAGEMENT, LLC | 82,948 | $1,601,000 | 0.31% |
| Monashee Investment Management LLC | 99,999 | $1,930,000 | 0.30% |
| Ikarian Capital, LLC | 438,684 | $8,467,000 | 0.28% |
| RTW INVESTMENTS, LP | 500,000 | $9,650,000 | 0.15% |